Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Doug Ingram
Pharma
Sarepta taps AbbVie vet Severino to take over for retiring CEO
Some five months after announcing the planned retirement of its longtime CEO Doug Ingram, Sarepta Therapeutics has found a prominent replacement.
Fraiser Kansteiner
Jul 27, 2026 11:36am
Sarepta, despite key trial flop, will seek full nod for DMD meds
Nov 4, 2025 7:56am
Sarepta sees delays in treatment after Elevidys death report
May 7, 2025 8:03am
Sarepta's Elevidys blows sales expectations out of the water
Nov 7, 2024 3:43pm
Sarepta CEO Ingram nabs $57M in 2017 pay
May 7, 2018 12:36pm
Sarepta’s CEO pick draws praise, takeover talk from analysts
Jun 29, 2017 5:58am
